Sponsored By:

4 Pharmaceutical Stocks to Buy Now

JNJ, BMY, WPI, RPRX improve in weekly rankings

   

This week, four Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).

Johnson & Johnson (NYSE:JNJ) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. In Portfolio Grader’s specific subcategories of Earnings Growth, Earnings Momentum, and Equity, JNJ also gets A’s. The stock’s dividend yield is 2.6%. For more information, get Portfolio Grader’s complete analysis of JNJ stock.

Bristol-Myers Squibb Company (NYSE:BMY) ups its rating to a B (“buy”) this week after earning a C (“hold”) in the week before. Bristol-Myers Squibb is a global company that develops, produces and sells pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of BMY stock.

Watson Pharmaceuticals’ (NYSE:WPI) ratings are looking better this week, moving up to an A from last week’s B. Watson develops, manufactures, markets, sells and distributes pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of WPI stock.

Repros Therapeutics (NASDAQ:RPRX) earns an A this week, jumping up from last week’s grade of B. Repros Therapeutics is a development stage biopharmaceutical company focusing on the development of oral small molecule drugs for major unmet medical needs. Shares of RPRX have increased 21% over the past month, better than the 1.3% decrease the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of RPRX stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, http://investorplace.com/2013/09/4-pharmaceutical-stocks-to-buy-now-jnj-bmy-wpi-21/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.